MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Neurite Orientation Dispersion and Density Imaging and Diffusion Kurtosis Imaging in Brainstem Nuclei for Subtypes of Parkinson’s Disease

    N. Joshi, I. Aisles, I. Shelley, K. Talekar, M. Alizadeh (Philadelphia, USA)

    Objective: We utilized neurite orientation dispersion and density imaging (NODDI) along with diffusion tensor and kurtosis imaging (DTI/DKI) to assess brainstem nuclei in Parkinson’s disease…
  • 2023 International Congress

    Home-based titration with Duodenal infusion of Levodopa in People with Parkinson’s disease: an observational feasibility study

    B. Biering-Sørensen, N. Nielsen, A. Isenberg, L. Olsen, M. Javidi, J. Vilhelmsen, M. Møller, M. Olsen, J. Clausen, T. Thomsen (Glostrup, Denmark)

    Objective: Primary objectives were to assess the feasibility and safety of LCIG home titration with use of telemedicine-assisted (TM) technology, and  patient/caregivers satisfaction. Secondly, to…
  • 2023 International Congress

    Novel application of the Timed Up and Go Scale as a reliable tool to measure functional improvement and fall prevention after inpatient Parkinson’s Disease specific rehabilitation for advanced stages of PD

    M. Mccrossin, L. Rubin, C. Claro, A. Persaud, E. Finlay, A. Sturman, D. Barreto, A. John, M. Tursi, A. Di Rocco (Glen Cove, USA)

    Objective: To determine whether the “Timed Up and Go” (TUG) scale can be effectively utilized in patients with advanced Parkinson’s disease (PD) as an outcome…
  • 2023 International Congress

    LRRK2 Inhibition by BIIB122/DNL151 Demonstrates Robust Target and Lysosomal Engagement: Pharmacokinetics, Pharmacodynamics and Safety in Phase 1 and Phase 1b Studies in Healthy and Parkinson’s Participants

    S. Dhuria, P. Roychowdhury, H. Wong, S. Huntwork-Rodriguez, H. Solanoy, M. Goo, R. Maciuca, O. Mabrouk, K. Fraser, K. Scearce-Levie, D. Graham, D. Jennings, M. Troyer (South San Francisco, USA)

    Objective: To characterize the pharmacokinetics (PK), pharmacodynamics, safety, and exposure-response (E-R) relationships of BIIB122/DNL151 to inform on clinical dose selection. Background: Increased LRRK2 kinase activity…
  • 2023 International Congress

    Olfactory dysfunction and neuropsychiatric manifestations in early drug-naïve Parkinson’s disease

    P. Julayanont (Phoenix, USA)

    Objective: To determine the severity of various neuropsychiatric disturbances in drug-naïve Parkinson’s disease (PD) patients with (PD-OD) and without olfactory dysfunction (PD-NOD) compared to healthy…
  • 2023 International Congress

    Common oscillatory patterns between Parkinson’s disease and heroin dependent patients: a resting-state EEG study

    D. Benis, V. Fleury, P. Krack (Geneva, Switzerland)

    Objective: We aimed to compare resting-state EEG oscillations between Parkinson’s disease (PD) patients during their ON and OFF Dopamine Replacement Therapy (DRT) states, heroin-dependent (HD)…
  • 2023 International Congress

    Gender-Specific Classification Models for Parkinson’s Disease using Non-Motor Symptoms and DNA Methylation Data

    MZA. Ali, PSD. Dholaniya (Hyderabad, India)

    Objective: In Parkinson's disease (PD) non-motor symptoms often appear before the motor symptoms. Detecting and understanding these non-motor symptoms and their possible genetic or epigenetic…
  • 2023 International Congress

    The role of structural changes in the retina and the vertical vestibulo-ocular reflex abnormality in gait disorders in Parkinson`s disease

    O. Alenikova, O. Davydova, N. Alenikov (Minsk, Belarus)

    Objective: Our goal was to investigate retinal structural changes as well as changes in visual cortex in PD patients with suppression deficiency of VOR and…
  • 2023 International Congress

    Epigenetic clock acceleration is linked to earlier onset and phenoconvertion of Rapid-eye-movement sleep behavior disorder

    K. Senkevich, A. Pelletier, C. Sato, A. Keil, Z. Gan-Or, A. Lang, R. Postuma, E. Rogaeva (Montreal, Canada)

    Objective: In the current study, we aim to evaluate whether Rapid-eye-movement sleep behavior disorder (RBD) age-at-onset and age-at-phenoconversion are associated with DNA methylation-age acceleration (DNAm-AA).…
  • 2023 International Congress

    Keyboard tapping performance in people with subjective REM sleep behaviour disorder

    H. Chohan, C. Simonet, M. Periñán, L. Pérez-Carbonell, G. Leschziner, A. Gill, J. Bestwick, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: The aim of this study was to compare the BRAIN test performance of people with subjective RBD (sRBD, defined by RBD screening questionnaire score >53)…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley